South Korean digital therapeutics startup Nunaps is accelerating the building and testing of its software-based brain disorder treatments after it raised 5 billion won ($4.2 million) in a Series A funding round, the company said in a statement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
